Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Schizophrenia Spectrum Disorder”

1,118 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,118 results

Post-approval studies (Phase 4)Study completedNCT05859698
What this trial is testing

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Neurocrine Biosciences 59
Large-scale testing (Phase 3)Study completedNCT00088478
What this trial is testing

Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Eli Lilly and Company 402
Not applicableUnknownNCT04064476
What this trial is testing

The Effect of Long-acting Antipsychotics on Schizophrenia Patients With Violence Risk

Who this might be right for
Schizophrenia
Huazhong University of Science and Technology 225
Not applicableLooking for participantsNCT05159349
What this trial is testing

Mental Health During the Whole Life Cycle of Community Patients With Schizophrenia

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 1,200
Not applicableEnded earlyNCT02144155
What this trial is testing

Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia

Who this might be right for
Schizophrenia
University of California, San Diego 14
Testing effectiveness (Phase 2)Study completedNCT07550387
What this trial is testing

A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia

Who this might be right for
SCHIZOPHRENIA 1 (Disorder)
Jiangsu Hansoh Pharmaceutical Co., Ltd. 363
Early research (Phase 1)Study completedNCT05516121
What this trial is testing

VLT-015 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
CF Pharma, LLC 15
Post-approval studies (Phase 4)Study completedNCT00817648
What this trial is testing

Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 120
Post-approval studies (Phase 4)Study completedNCT00634348
What this trial is testing

A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 256
Not applicableStudy completedNCT02409823
What this trial is testing

Clinical Registry of Patients Under Treatment With Atypical Antipsychotics

Who this might be right for
SchizophreniaMajor Depressive DisorderBipolar Depressive Disorder+1 more
Pontifical Catholic University of Argentina 665
Large-scale testing (Phase 3)Study completedNCT00549718
What this trial is testing

Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia

Who this might be right for
Schizophrenia
Sumitomo Pharma America, Inc. 489
Not applicableStudy completedNCT01494623
What this trial is testing

The Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Working Memory

Who this might be right for
Schizophrenia
Centre for Addiction and Mental Health 122
Large-scale testing (Phase 3)Study completedNCT01235559
What this trial is testing

RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)

Who this might be right for
Schizophrenia
Hoffmann-La Roche 604
Post-approval studies (Phase 4)Study completedNCT01036282
What this trial is testing

Cognitive Skills Training Using Computer for Patients With Severe Mental Illness

Who this might be right for
SchizophreniaSchizoaffective Disorder
Nathan Kline Institute for Psychiatric Research 448
Large-scale testing (Phase 3)Study completedNCT00240708
What this trial is testing

The Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Janssen Pharmaceutical K.K. 205
Not applicableWithdrawnNCT00934908
What this trial is testing

Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine

Who this might be right for
Bipolar DisorderSchizophrenia
Medical University of South Carolina
Large-scale testing (Phase 3)Study completedNCT00420823
What this trial is testing

Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment

Who this might be right for
Psychotic Disorders
Melbourne Health 121
Testing effectiveness (Phase 2)Study completedNCT00827918
What this trial is testing

Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)

Who this might be right for
Schizophrenia
Merck Sharp & Dohme LLC 216
Large-scale testing (Phase 3)Study completedNCT01456897
What this trial is testing

A Long-term Trial of OPC-34712 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Co., Ltd. 282
Post-approval studies (Phase 4)Study completedNCT00392197
What this trial is testing

Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Co., Ltd. 111
Next Page